Back to EUR-Lex homepage

EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search
You are here

Document 62009TJ0492

Rettens dom (Ottende Afdeling) af 7. juni 2012.
Meda Pharma GmbH & Co. KG mod Kontoret for Harmonisering i det Indre Marked (Varemærker og Design) (KHIM).
EF-varemærker - indsigelsessag - international registrering, hvor Det Europæiske Fællesskab er designeret - ordmærket ALLERNIL - ansøgning om EF-ordmærket ALLERNIL - det ældre nationale ordmærke ALLERGODIL - relativ registreringshindring - ingen risiko for forveksling - artikel 8, stk. 1, litra b), i forordning (EF) nr. 207/2009 - begrundelse - artikel 75 i forordning nr. 207/2009.
Forenede sager T-492/09 og T-147/10.

Samling af Afgørelser 2012 -00000

ECLI identifier: ECLI:EU:T:2012:281





Judgment of the General Court (Eighth Chamber) of 7 June 2012 —
Meda Pharma v OHIM — Nycomed (ALLERNIL)

(Joined Cases T-492/09 and T-147/10)

Community trade mark — Opposition proceedings — International registration designating the European Community — Word mark ALLERNIL — Application for Community word mark ALLERNIL — Earlier national word mark ALLERGODIL — Relative ground for refusal — No likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 207/2009 — Grounds — Article 75 of Regulation No 207/2009

Community trade mark — Definition and acquisition of the Community trade mark — Relative grounds for refusal — Opposition by the proprietor of an earlier identical or similar mark registered for identical or similar goods or services — Likelihood of confusion with the earlier mark (Council Regulation No 207/2009, Art. 8(1)(b)) (see paras 30, 52)

Re:

Two actions brought against two decisions of the Fourth Board of Appeal of OHIM of 29 September 2009 (Cases R 1386/2007-4 and R 697/2007-4), relating to opposition proceedings between Meda Pharma GmbH & Co. KG and Nycomed GmbH.

Operative part

The Court:

1.

Dismisses the actions;

2.

Orders Meda Pharma GmbH & Co. KG to pay the costs incurred in Joined Cases T-492/09 and T-147/10.

Top